Impinj Inc (PI) · Insider trading
What Impinj's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$170.38M
4 insiders, 1% under a plan
Net, 12 months
−$170.38M
bought less sold
Latest filing
2026-10-13
filings read to 2026-10-19
Who traded, two years
| Insider | Bought | Sold | Trades | Last trade | Holds after |
|---|---|---|---|---|---|
| Gibson Daniel PatrickDirector | – | $383.18M | 36 | 2025-12-15 | – |
| Sylebra Capital LLCDirector | – | $57.69M | 20 | 2026-06-09 | – |
| Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | – | $20.63M | 58 | 2025-09-16 | 299,288 |
| Baker CaryCHIEF FINANCIAL OFFICER | – | $5.25M | 17 | 2026-09-21 | 80,388 |
| Dossett JeffreyCHIEF REVENUE OFFICER | – | $3.21M | 18 | 2025-02-21 | 73,674 |
| Mecklai HusseinCHIEF OPERATING OFFICER | – | $2.59M | 9 | 2025-02-21 | 72,674 |
| Phelan Cathal GDirector, CHIEF INNOVATION OFFICER | – | $2.54M | 9 | 2025-02-21 | 8,265 |
| Washington MironDirector | – | $192,965 | 2 | 2026-09-15 | 4,354 |
Open-market purchases and sales
Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Holds after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-21 | Baker CaryCHIEF FINANCIAL OFFICER | Saleplan | 8,892 | 185.00 | $1.65M | 80,388 | Form 4 |
| 2026-09-15 | Washington MironDirector | Sale | 800 | 173.26 | $138,608 | 4,354 | Form 4 |
| 2026-08-10 | Baker CaryCHIEF FINANCIAL OFFICER | Saleplan | 1,429 | 185.00 | $264,365 | 88,226 | Form 4 |
| 2026-06-09 | Sylebra Capital LLCDirector | Saleindirect | 19,105 | 127.36 | $2.43M | 775,943 | Form 4/A |
| 2026-06-08 | Sylebra Capital LLCDirector | Saleindirect | 12,528 | 125.97 | $1.58M | 828,048 | Form 4/A |
| 2026-06-08 | Sylebra Capital LLCDirector | Saleindirect | 33,000 | 130.07 | $4.29M | 795,048 | Form 4/A |
| 2026-06-05 | Sylebra Capital LLCDirector | Saleindirect | 11,602 | 128.87 | $1.50M | 876,453 | Form 4 |
| 2026-06-05 | Sylebra Capital LLCDirector | Saleindirect | 35,877 | 122.50 | $4.39M | 840,576 | Form 4 |
| 2026-06-04 | Sylebra Capital LLCDirector | Saleindirect | 33,412 | 136.84 | $4.57M | 888,055 | Form 4 |
| 2026-06-03 | Sylebra Capital LLCDirector | Saleindirect | 6,313 | 139.17 | $878,580 | 921,467 | Form 4 |
| 2026-06-02 | Sylebra Capital LLCDirector | Saleindirect | 38,724 | 142.31 | $5.51M | 927,780 | Form 4 |
| 2026-06-01 | Sylebra Capital LLCDirector | Saleindirect | 7,163 | 144.29 | $1.03M | 966,504 | Form 4 |
| 2026-05-29 | Sylebra Capital LLCDirector | Saleindirect | 48,504 | 150.78 | $7.31M | 973,667 | Form 4 |
| 2026-05-11 | Sylebra Capital LLCDirector | Saleindirect | 24,126 | 154.46 | $3.73M | 1,034,877 | Form 4 |
| 2026-05-11 | Sylebra Capital LLCDirector | Saleindirect | 12,706 | 154.46 | $1.96M | 1,022,171 | Form 4 |
| 2026-05-11 | Sylebra Capital LLCDirector | Saleindirect | 24,126 | 154.46 | $3.73M | 1,034,877 | Form 4/A |
| 2026-05-11 | Sylebra Capital LLCDirector | Saleindirect | 12,706 | 154.46 | $1.96M | 1,022,171 | Form 4/A |
| 2026-05-08 | Sylebra Capital LLCDirector | Saleindirect | 1,560 | 151.32 | $236,059 | 1,068,525 | Form 4 |
| 2026-05-08 | Sylebra Capital LLCDirector | Saleindirect | 9,522 | 149.97 | $1.43M | 1,059,003 | Form 4 |
| 2026-05-08 | Sylebra Capital LLCDirector | Saleindirect | 25,896 | 152.73 | $3.96M | 1,070,085 | Form 4/A |
| 2026-05-08 | Sylebra Capital LLCDirector | Saleindirect | 1,560 | 151.32 | $236,059 | 1,068,525 | Form 4/A |
| 2026-05-08 | Sylebra Capital LLCDirector | Saleindirect | 9,522 | 149.97 | $1.43M | 1,059,003 | Form 4/A |
| 2026-05-07 | Sylebra Capital LLCDirector | Saleindirect | 36,171 | 152.73 | $5.52M | 1,095,981 | Form 4/A |
| 2025-12-15 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 134,629 | 150.36 | $20.24M | 1,132,152 | Form 4 |
| 2025-12-12 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 50,573 | 146.62 | $7.42M | 1,266,781 | Form 4 |
| 2025-12-11 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 95,345 | 152.87 | $14.58M | 1,317,354 | Form 4 |
| 2025-12-10 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 84,604 | 155.49 | $13.16M | 1,412,699 | Form 4 |
| 2025-12-09 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 40 | 160.01 | $6,400 | 1,497,303 | Form 4 |
| 2025-12-08 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 2,494 | 160.72 | $400,836 | 1,497,343 | Form 4 |
| 2025-12-05 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 1,373 | 161.04 | $221,108 | 1,499,837 | Form 4 |
| 2025-12-04 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 3,167 | 160.59 | $508,589 | 1,501,210 | Form 4 |
| 2025-12-03 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 41,221 | 167.97 | $6.92M | 1,504,377 | Form 4 |
| 2025-12-02 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 41,874 | 168.23 | $7.04M | 1,545,598 | Form 4 |
| 2025-12-01 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 31,058 | 167.02 | $5.19M | 1,587,472 | Form 4 |
| 2025-11-28 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 22,297 | 172.62 | $3.85M | 1,618,530 | Form 4 |
| 2025-11-26 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 34,556 | 171.80 | $5.94M | 1,640,827 | Form 4 |
| 2025-11-25 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 46,110 | 167.73 | $7.73M | 1,675,383 | Form 4 |
| 2025-11-24 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 31,952 | 159.42 | $5.09M | 1,721,493 | Form 4 |
| 2025-11-21 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 3,046 | 155.10 | $472,435 | 1,753,445 | Form 4 |
| 2025-11-20 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 8,081 | 156.32 | $1.26M | 1,756,491 | Form 4 |
129 more
| 2025-11-12 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 3,772 | 156.30 | $589,564 | 1,764,572 | Form 4 |
| 2025-11-11 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 30,000 | 155.63 | $4.67M | 1,768,344 | Form 4 |
| 2025-11-07 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 6,246 | 162.16 | $1.01M | 1,798,344 | Form 4 |
| 2025-11-07 | Washington MironDirector | Sale | 342 | 158.94 | $54,357 | 2,040 | Form 4 |
| 2025-11-06 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 23,157 | 171.95 | $3.98M | 1,804,590 | Form 4 |
| 2025-11-03 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 1,513 | 202.01 | $305,641 | 1,827,747 | Form 4 |
| 2025-09-16 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 1,821 | 186.43 | $339,489 | 299,288 | Form 4 |
| 2025-09-16 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 1,073 | 187.52 | $201,209 | 298,215 | Form 4 |
| 2025-09-16 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 850 | 189.21 | $160,828 | 297,365 | Form 4 |
| 2025-09-16 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 340 | 190.26 | $64,688 | 297,025 | Form 4 |
| 2025-09-16 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 12 | 191.76 | $2,301 | 297,013 | Form 4 |
| 2025-09-15 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 568 | 179.26 | $101,820 | 305,541 | Form 4 |
| 2025-09-15 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 467 | 180.65 | $84,364 | 305,074 | Form 4 |
| 2025-09-15 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 1,909 | 181.84 | $347,133 | 303,165 | Form 4 |
| 2025-09-15 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 1,260 | 182.77 | $230,290 | 301,905 | Form 4 |
| 2025-09-15 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 796 | 183.47 | $146,042 | 301,109 | Form 4 |
| 2025-09-10 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 300,000 | 196.24 | $58.87M | 1,829,260 | Form 4 |
| 2025-09-09 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 330 | 190.42 | $62,839 | 340,779 | Form 4 |
| 2025-09-09 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 199 | 191.30 | $38,069 | 340,580 | Form 4 |
| 2025-09-09 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 510 | 192.84 | $98,348 | 340,070 | Form 4 |
| 2025-09-09 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 1,332 | 194.18 | $258,648 | 338,738 | Form 4 |
| 2025-09-09 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 1,120 | 195.10 | $218,512 | 337,618 | Form 4 |
| 2025-09-09 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 249 | 196.34 | $48,889 | 337,369 | Form 4 |
| 2025-09-09 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 790 | 197.23 | $155,812 | 336,579 | Form 4 |
| 2025-09-09 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 303 | 197.86 | $59,952 | 336,276 | Form 4 |
| 2025-09-09 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 167 | 199.77 | $33,362 | 336,109 | Form 4 |
| 2025-09-08 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 1,893 | 191.81 | $363,096 | 344,216 | Form 4 |
| 2025-09-08 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 3,007 | 192.58 | $579,088 | 341,209 | Form 4 |
| 2025-09-08 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 100 | 193.30 | $19,330 | 341,109 | Form 4 |
| 2025-09-03 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 80 | 186.37 | $14,910 | 351,029 | Form 4 |
| 2025-09-03 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 925 | 187.96 | $173,863 | 350,104 | Form 4 |
| 2025-09-03 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 1,438 | 189.49 | $272,487 | 348,666 | Form 4 |
| 2025-09-03 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 2,557 | 190.15 | $486,214 | 346,109 | Form 4 |
| 2025-09-02 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 4,517 | 180.56 | $815,590 | 351,592 | Form 4 |
| 2025-09-02 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 483 | 181.35 | $87,592 | 351,109 | Form 4 |
| 2025-08-29 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 2,000 | 188.39 | $376,780 | 359,109 | Form 4 |
| 2025-08-29 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 2,800 | 189.39 | $530,292 | 356,309 | Form 4 |
| 2025-08-29 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 200 | 190.28 | $38,056 | 356,109 | Form 4 |
| 2025-08-28 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 1,112 | 185.93 | $206,754 | 364,997 | Form 4 |
| 2025-08-28 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 784 | 186.80 | $146,451 | 364,213 | Form 4 |
| 2025-08-28 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 1,749 | 188.14 | $329,057 | 362,464 | Form 4 |
| 2025-08-28 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 960 | 189.06 | $181,498 | 361,504 | Form 4 |
| 2025-08-28 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 325 | 190.33 | $61,857 | 361,179 | Form 4 |
| 2025-08-28 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Saleplan | 70 | 190.79 | $13,355 | 361,109 | Form 4 |
| 2025-02-21 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Sale | 3,031 | 97.74 | $296,250 | 359,379 | Form 4 |
| 2025-02-21 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Sale | 1,348 | 98.38 | $132,616 | 358,031 | Form 4 |
| 2025-02-21 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Sale | 3,875 | 99.70 | $386,338 | 354,156 | Form 4 |
| 2025-02-21 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Sale | 80 | 100.25 | $8,020 | 354,076 | Form 4 |
| 2025-02-21 | Dossett JeffreyCHIEF REVENUE OFFICER | Sale | 878 | 97.75 | $85,824 | 73,674 | Form 4 |
| 2025-02-21 | Dossett JeffreyCHIEF REVENUE OFFICER | Sale | 507 | 98.37 | $49,874 | 73,167 | Form 4 |
| 2025-02-21 | Dossett JeffreyCHIEF REVENUE OFFICER | Sale | 1,281 | 99.72 | $127,741 | 71,886 | Form 4 |
| 2025-02-21 | Baker CaryCHIEF FINANCIAL OFFICER | Sale | 701 | 97.82 | $68,572 | 77,303 | Form 4 |
| 2025-02-21 | Baker CaryCHIEF FINANCIAL OFFICER | Sale | 234 | 98.86 | $23,133 | 77,069 | Form 4 |
| 2025-02-21 | Baker CaryCHIEF FINANCIAL OFFICER | Sale | 618 | 99.79 | $61,670 | 76,451 | Form 4 |
| 2025-02-21 | Mecklai HusseinCHIEF OPERATING OFFICER | Sale | 1,412 | 97.77 | $138,051 | 72,674 | Form 4 |
| 2025-02-21 | Mecklai HusseinCHIEF OPERATING OFFICER | Sale | 544 | 98.50 | $53,584 | 72,130 | Form 4 |
| 2025-02-21 | Mecklai HusseinCHIEF OPERATING OFFICER | Sale | 1,783 | 99.74 | $177,836 | 70,347 | Form 4 |
| 2025-02-21 | Phelan Cathal GDirector, CHIEF INNOVATION OFFICER | Sale | 225 | 97.77 | $21,998 | 8,265 | Form 4 |
| 2025-02-21 | Phelan Cathal GDirector, CHIEF INNOVATION OFFICER | Sale | 72 | 98.47 | $7,090 | 8,193 | Form 4 |
| 2025-02-21 | Phelan Cathal GDirector, CHIEF INNOVATION OFFICER | Sale | 268 | 99.68 | $26,714 | 7,925 | Form 4 |
| 2025-01-13 | Mecklai HusseinCHIEF OPERATING OFFICER | Sale | 168 | 140.67 | $23,633 | 61,756 | Form 4 |
| 2025-01-13 | Mecklai HusseinCHIEF OPERATING OFFICER | Sale | 170 | 141.35 | $24,030 | 61,586 | Form 4 |
| 2025-01-13 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Sale | 371 | 140.63 | $52,174 | 334,326 | Form 4 |
| 2025-01-13 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Sale | 470 | 141.33 | $66,425 | 333,856 | Form 4 |
| 2025-01-13 | Baker CaryCHIEF FINANCIAL OFFICER | Sale | 140 | 140.56 | $19,678 | 71,904 | Form 4 |
| 2025-01-13 | Baker CaryCHIEF FINANCIAL OFFICER | Sale | 150 | 141.33 | $21,200 | 71,754 | Form 4 |
| 2025-01-13 | Dossett JeffreyCHIEF REVENUE OFFICER | Sale | 155 | 140.63 | $21,798 | 67,275 | Form 4 |
| 2025-01-13 | Dossett JeffreyCHIEF REVENUE OFFICER | Sale | 223 | 141.34 | $31,519 | 67,052 | Form 4 |
| 2024-12-24 | Baker CaryCHIEF FINANCIAL OFFICER | Sale | 499 | 146.06 | $72,884 | 71,107 | Form 4 |
| 2024-12-24 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Sale | 1,504 | 146.22 | $219,915 | 331,572 | Form 4 |
| 2024-12-24 | Dossett JeffreyCHIEF REVENUE OFFICER | Sale | 575 | 146.06 | $83,984 | 66,185 | Form 4 |
| 2024-12-24 | Dossett JeffreyCHIEF REVENUE OFFICER | Sale | 5 | 146.73 | $734 | 66,180 | Form 4 |
| 2024-12-24 | Mecklai HusseinCHIEF OPERATING OFFICER | Sale | 816 | 146.06 | $119,185 | 60,840 | Form 4 |
| 2024-12-24 | Mecklai HusseinCHIEF OPERATING OFFICER | Sale | 10 | 146.73 | $1,467 | 60,830 | Form 4 |
| 2024-12-24 | Phelan Cathal GDirector, CHIEF INNOVATION OFFICER | Sale | 37 | 145.40 | $5,380 | 7,152 | Form 4 |
| 2024-12-24 | Phelan Cathal GDirector, CHIEF INNOVATION OFFICER | Sale | 173 | 146.20 | $25,293 | 6,979 | Form 4 |
| 2024-11-21 | Phelan Cathal GDirector, CHIEF INNOVATION OFFICER | Sale | 697 | 186.14 | $129,740 | 6,776 | Form 4 |
| 2024-11-14 | Dossett JeffreyCHIEF REVENUE OFFICER | Saleplan | 1,192 | 179.29 | $213,714 | 71,602 | Form 4 |
| 2024-11-14 | Dossett JeffreyCHIEF REVENUE OFFICER | Saleplan | 1,698 | 180.08 | $305,776 | 69,904 | Form 4 |
| 2024-11-14 | Dossett JeffreyCHIEF REVENUE OFFICER | Saleplan | 2,298 | 180.99 | $415,915 | 67,606 | Form 4 |
| 2024-11-14 | Dossett JeffreyCHIEF REVENUE OFFICER | Saleplan | 905 | 181.99 | $164,701 | 66,701 | Form 4 |
| 2024-11-14 | Dossett JeffreyCHIEF REVENUE OFFICER | Saleplan | 651 | 183.02 | $119,146 | 66,050 | Form 4 |
| 2024-11-14 | Dossett JeffreyCHIEF REVENUE OFFICER | Saleplan | 756 | 184.55 | $139,520 | 65,294 | Form 4 |
| 2024-11-13 | Dossett JeffreyCHIEF REVENUE OFFICER | Saleplan | 1,366 | 191.88 | $262,108 | 71,428 | Form 4 |
| 2024-11-13 | Dossett JeffreyCHIEF REVENUE OFFICER | Saleplan | 2,281 | 192.73 | $439,617 | 69,147 | Form 4 |
| 2024-11-13 | Dossett JeffreyCHIEF REVENUE OFFICER | Saleplan | 1,562 | 193.87 | $302,825 | 67,585 | Form 4 |
| 2024-11-13 | Dossett JeffreyCHIEF REVENUE OFFICER | Saleplan | 2,087 | 194.69 | $406,318 | 65,498 | Form 4 |
| 2024-11-13 | Dossett JeffreyCHIEF REVENUE OFFICER | Saleplan | 204 | 195.83 | $39,949 | 65,294 | Form 4 |
| 2024-11-13 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 2,550 | 195.41 | $498,296 | 2,129,260 | Form 4 |
| 2024-11-12 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 11,926 | 198.56 | $2.37M | 2,131,810 | Form 4 |
| 2024-11-11 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 78,616 | 201.79 | $15.86M | 2,143,736 | Form 4 |
| 2024-11-08 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 25,000 | 202.14 | $5.05M | 2,447,352 | Form 4 |
| 2024-11-08 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 225,000 | 203.10 | $45.70M | 2,222,352 | Form 4 |
| 2024-11-08 | Phelan Cathal GDirector, CHIEF INNOVATION OFFICER | Sale | 7,569 | 200.28 | $1.52M | 10,078 | Form 4 |
| 2024-11-08 | Phelan Cathal GDirector, CHIEF INNOVATION OFFICER | Sale | 2,968 | 201.64 | $598,468 | 7,110 | Form 4 |
| 2024-11-08 | Phelan Cathal GDirector, CHIEF INNOVATION OFFICER | Sale | 1,012 | 202.36 | $204,788 | 6,098 | Form 4 |
| 2024-11-07 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Sale | 1,271 | 197.62 | $251,175 | 340,577 | Form 4 |
| 2024-11-07 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Sale | 8,953 | 198.87 | $1.78M | 331,624 | Form 4 |
| 2024-11-07 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Sale | 2,366 | 199.52 | $472,064 | 329,258 | Form 4 |
| 2024-11-07 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 135,191 | 201.63 | $27.26M | 2,472,352 | Form 4 |
| 2024-11-06 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Sale | 1,504 | 201.54 | $303,116 | 362,934 | Form 4 |
| 2024-11-06 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Sale | 2,786 | 202.87 | $565,196 | 360,148 | Form 4 |
| 2024-11-06 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Sale | 3,940 | 203.81 | $803,011 | 356,208 | Form 4 |
| 2024-11-06 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Sale | 1,241 | 204.67 | $253,995 | 354,967 | Form 4 |
| 2024-11-06 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Sale | 769 | 206.03 | $158,437 | 354,198 | Form 4 |
| 2024-11-06 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Sale | 2,350 | 207.13 | $486,756 | 351,848 | Form 4 |
| 2024-11-06 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 89,809 | 201.78 | $18.12M | 2,607,543 | Form 4 |
| 2024-11-05 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 206,153 | 196.58 | $40.53M | 2,697,352 | Form 4 |
| 2024-11-04 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 51,823 | 195.02 | $10.11M | 2,947,352 | Form 4 |
| 2024-11-04 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 43,847 | 195.43 | $8.57M | 2,903,505 | Form 4 |
| 2024-11-01 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 22,373 | 195.00 | $4.36M | 2,999,175 | Form 4 |
| 2024-10-30 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Sale | 373 | 195.23 | $72,821 | 294,591 | Form 4 |
| 2024-10-30 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Sale | 153 | 196.20 | $30,019 | 294,438 | Form 4 |
| 2024-10-30 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 32,031 | 195.36 | $6.26M | 3,021,548 | Form 4 |
| 2024-10-29 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Sale | 9,789 | 200.09 | $1.96M | 319,123 | Form 4 |
| 2024-10-29 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Sale | 15,461 | 201.81 | $3.12M | 303,662 | Form 4 |
| 2024-10-29 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Sale | 9,224 | 202.52 | $1.87M | 294,438 | Form 4 |
| 2024-10-29 | Gibson Daniel PatrickDirectorwith Sylebra Capital LLC | Saleindirect | 143,773 | 201.95 | $29.03M | 3,053,579 | Form 4 |
| 2024-10-28 | Baker CaryCHIEF FINANCIAL OFFICER | Sale | 570 | 200.58 | $114,331 | 85,526 | Form 4 |
| 2024-10-28 | Baker CaryCHIEF FINANCIAL OFFICER | Sale | 576 | 201.40 | $116,006 | 84,950 | Form 4 |
| 2024-10-28 | Baker CaryCHIEF FINANCIAL OFFICER | Sale | 830 | 202.38 | $167,975 | 84,120 | Form 4 |
| 2024-10-28 | Baker CaryCHIEF FINANCIAL OFFICER | Sale | 1,294 | 203.41 | $263,213 | 82,826 | Form 4 |
| 2024-10-28 | Baker CaryCHIEF FINANCIAL OFFICER | Sale | 4,970 | 204.37 | $1.02M | 77,856 | Form 4 |
| 2024-10-28 | Baker CaryCHIEF FINANCIAL OFFICER | Sale | 2,510 | 205.27 | $515,228 | 75,346 | Form 4 |
| 2024-10-28 | Baker CaryCHIEF FINANCIAL OFFICER | Sale | 2,089 | 206.43 | $431,232 | 73,257 | Form 4 |
| 2024-10-28 | Baker CaryCHIEF FINANCIAL OFFICER | Sale | 1,065 | 207.56 | $221,051 | 72,192 | Form 4 |
| 2024-10-28 | Baker CaryCHIEF FINANCIAL OFFICER | Sale | 1,096 | 208.68 | $228,713 | 71,096 | Form 4 |
| 2024-10-28 | Mecklai HusseinCHIEF OPERATING OFFICER | Sale | 6,775 | 204.46 | $1.39M | 63,266 | Form 4 |
| 2024-10-28 | Mecklai HusseinCHIEF OPERATING OFFICER | Sale | 3,225 | 205.37 | $662,318 | 60,041 | Form 4 |
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
91 × option exercise24 × shares withheld for tax14 × gift6 × grant or award5 × other
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-10-12 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Gift G | −10,000 | – | 346,265 | Form 4 |
| 2026-09-23 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Option exercise M | +1,224 | – | 355,645 | Form 4 |
| 2026-09-23 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Option exercise M | +1,817 | – | 357,462 | Form 4 |
| 2026-09-23 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Shares withheld for tax F | −1,197 | 177.20 | 356,265 | Form 4 |
| 2026-09-23 | Baker CaryCHIEF FINANCIAL OFFICER | Option exercise M | +479 | – | 80,867 | Form 4 |
| 2026-09-23 | Baker CaryCHIEF FINANCIAL OFFICER | Option exercise M | +596 | – | 81,463 | Form 4 |
| 2026-09-23 | Baker CaryCHIEF FINANCIAL OFFICER | Shares withheld for tax F | −424 | 177.20 | 81,039 | Form 4 |
| 2026-09-14 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Gift G | −10,000 | – | 354,421 | Form 4 |
| 2026-08-20 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Option exercise M | +3,753 | – | 365,898 | Form 4 |
| 2026-08-20 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Shares withheld for tax F | −1,477 | 159.73 | 364,421 | Form 4 |
| 2026-08-20 | Baker CaryCHIEF FINANCIAL OFFICER | Option exercise M | +1,739 | – | 89,965 | Form 4 |
| 2026-08-20 | Baker CaryCHIEF FINANCIAL OFFICER | Shares withheld for tax F | −685 | 159.73 | 89,280 | Form 4 |
| 2026-08-17 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Gift G | −10,000 | – | 362,145 | Form 4 |
| 2026-07-13 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Gift G | −10,000 | – | 372,145 | Form 4 |
| 2026-06-23 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Option exercise M | +1,223 | – | 381,525 | Form 4 |
| 2026-06-23 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Option exercise M | +1,817 | – | 383,342 | Form 4 |
| 2026-06-23 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Shares withheld for tax F | −1,197 | 125.22 | 382,145 | Form 4 |
| 2026-06-23 | Baker CaryCHIEF FINANCIAL OFFICER | Option exercise M | +479 | – | 89,482 | Form 4 |
| 2026-06-23 | Baker CaryCHIEF FINANCIAL OFFICER | Option exercise M | +597 | – | 90,079 | Form 4 |
| 2026-06-23 | Baker CaryCHIEF FINANCIAL OFFICER | Shares withheld for tax F | −424 | 125.22 | 89,655 | Form 4 |
| 2026-06-15 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Gift G | −10,000 | – | 380,302 | Form 4 |
| 2026-05-28 | Sanghi SteveDirector | Option exercise M | +3,425 | – | 13,274 | Form 4 |
| 2026-05-28 | Padval UmeshDirector | Option exercise M | +3,114 | – | 6,654 | Form 4 |
| 2026-05-28 | Rao MeeraDirector | Option exercise M | +3,114 | – | 11,322 | Form 4 |
| 2026-05-28 | Gibson Daniel PatrickDirector | Option exercise M | +3,114 | – | 23,010 | Form 4 |
| 2026-05-28 | Washington MironDirector | Option exercise M | +3,114 | – | 5,154 | Form 4 |
| 2026-05-26 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Other J | +180,000 | 156.68 | 570,302 | Form 4 |
| 2026-05-26 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Other J | −180,000 | 156.68 | 390,302 | Form 4 |
| 2026-03-23 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Option exercise M | +2,594 | – | 389,479 | Form 4 |
| 2026-03-23 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Option exercise M | +1,224 | – | 390,703 | Form 4 |
| 2026-03-23 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Option exercise M | +1,817 | – | 392,520 | Form 4 |
| 2026-03-23 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Shares withheld for tax F | −2,218 | 101.17 | 390,302 | Form 4 |
| 2026-03-23 | Baker CaryCHIEF FINANCIAL OFFICER | Option exercise M | +782 | – | 88,659 | Form 4 |
| 2026-03-23 | Baker CaryCHIEF FINANCIAL OFFICER | Option exercise M | +479 | – | 89,138 | Form 4 |
| 2026-03-23 | Baker CaryCHIEF FINANCIAL OFFICER | Option exercise M | +597 | – | 89,735 | Form 4 |
| 2026-03-23 | Baker CaryCHIEF FINANCIAL OFFICER | Shares withheld for tax F | −732 | 101.17 | 89,003 | Form 4 |
| 2026-02-20 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Grant or award A | +21,734 | – | 394,320 | Form 4 |
| 2026-02-20 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Shares withheld for tax F | −7,435 | 127.92 | 386,885 | Form 4 |
| 2026-02-20 | Baker CaryCHIEF FINANCIAL OFFICER | Grant or award A | +8,508 | – | 90,111 | Form 4 |
| 2026-02-20 | Baker CaryCHIEF FINANCIAL OFFICER | Shares withheld for tax F | −2,234 | 127.92 | 87,877 | Form 4 |
| 2026-02-17 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Gift G | −1,836 | – | 372,586 | Form 4 |
| 2025-12-23 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Option exercise M | +2,594 | – | 373,599 | Form 4 |
| 2025-12-23 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Option exercise M | +1,224 | – | 374,823 | Form 4 |
| 2025-12-23 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Option exercise M | +1,817 | – | 376,640 | Form 4 |
| 2025-12-23 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Shares withheld for tax F | −2,218 | 171.99 | 374,422 | Form 4 |
| 2025-12-23 | Baker CaryCHIEF FINANCIAL OFFICER | Option exercise M | +781 | – | 81,260 | Form 4 |
| 2025-12-23 | Baker CaryCHIEF FINANCIAL OFFICER | Option exercise M | +479 | – | 81,739 | Form 4 |
| 2025-12-23 | Baker CaryCHIEF FINANCIAL OFFICER | Option exercise M | +596 | – | 82,335 | Form 4 |
| 2025-12-23 | Baker CaryCHIEF FINANCIAL OFFICER | Shares withheld for tax F | −732 | 171.99 | 81,603 | Form 4 |
| 2025-11-25 | Baker CaryCHIEF FINANCIAL OFFICER | Gift G | −1,000 | – | 80,479 | Form 4 |
| 2025-11-19 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Gift G | −7,000 | – | 371,005 | Form 4 |
| 2025-10-30 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Option exercise M | +23,500 | 22.40 | 378,005 | Form 4 |
| 2025-09-23 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Option exercise M | +2,594 | – | 353,682 | Form 4 |
| 2025-09-23 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Option exercise M | +1,224 | – | 354,906 | Form 4 |
| 2025-09-23 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Option exercise M | +1,818 | – | 356,724 | Form 4 |
| 2025-09-23 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Shares withheld for tax F | −2,219 | 184.97 | 354,505 | Form 4 |
| 2025-09-23 | Baker CaryCHIEF FINANCIAL OFFICER | Option exercise M | +781 | – | 81,135 | Form 4 |
| 2025-09-23 | Baker CaryCHIEF FINANCIAL OFFICER | Option exercise M | +479 | – | 81,614 | Form 4 |
| 2025-09-23 | Baker CaryCHIEF FINANCIAL OFFICER | Option exercise M | +597 | – | 82,211 | Form 4 |
| 2025-09-23 | Baker CaryCHIEF FINANCIAL OFFICER | Shares withheld for tax F | −732 | 184.97 | 81,479 | Form 4 |
| 2025-09-18 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Option exercise M | +47,039 | 33.77 | 344,052 | Form 4 |
| 2025-09-18 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Option exercise M | +7,036 | 22.40 | 351,088 | Form 4 |
| 2025-09-12 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Gift G | −30,000 | – | 306,109 | Form 4 |
| 2025-06-23 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Option exercise M | +2,593 | – | 365,287 | Form 4 |
| 2025-06-23 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Option exercise M | +1,223 | – | 366,510 | Form 4 |
| 2025-06-23 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Option exercise M | +1,817 | – | 368,327 | Form 4 |
| 2025-06-23 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Shares withheld for tax F | −2,218 | 106.34 | 366,109 | Form 4 |
| 2025-06-23 | Baker CaryCHIEF FINANCIAL OFFICER | Option exercise M | +781 | – | 80,011 | Form 4 |
| 2025-06-23 | Baker CaryCHIEF FINANCIAL OFFICER | Option exercise M | +479 | – | 80,490 | Form 4 |
| 2025-06-23 | Baker CaryCHIEF FINANCIAL OFFICER | Option exercise M | +596 | – | 81,086 | Form 4 |
| 2025-06-23 | Baker CaryCHIEF FINANCIAL OFFICER | Shares withheld for tax F | −732 | 106.34 | 80,354 | Form 4 |
| 2025-06-05 | Gibson Daniel PatrickDirector | Option exercise M | +1,811 | – | 19,896 | Form 4 |
| 2025-06-05 | Washington MironDirector | Option exercise M | +1,811 | – | 2,382 | Form 4 |
| 2025-06-05 | Sanghi SteveDirector | Option exercise M | +1,992 | – | 9,849 | Form 4 |
| 2025-06-05 | Rao MeeraDirector | Option exercise M | +1,811 | – | 8,208 | Form 4 |
| 2025-06-05 | Padval UmeshDirector | Option exercise M | +1,811 | – | 3,540 | Form 4 |
| 2025-05-20 | Phelan Cathal GDirector, CHIEF INNOVATION OFFICER | Option exercise M | +1,375 | – | 10,923 | Form 4 |
| 2025-05-20 | Phelan Cathal GDirector, CHIEF INNOVATION OFFICER | Shares withheld for tax F | −492 | 123.33 | 10,431 | Form 4 |
| 2025-05-01 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Other J | −288,132 | – | 199,362 | Form 4 |
| 2025-04-14 | Baker CaryCHIEF FINANCIAL OFFICER | Shares withheld for tax F | −370 | 66.77 | 79,230 | Form 4 |
| 2025-04-14 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Shares withheld for tax F | −1,230 | 66.77 | 362,694 | Form 4 |
| 2025-04-14 | Mecklai HusseinCHIEF OPERATING OFFICER | Shares withheld for tax F | −431 | 66.77 | 75,882 | Form 4 |
| 2025-04-12 | Baker CaryCHIEF FINANCIAL OFFICER | Option exercise M | +938 | – | 79,600 | Form 4 |
| 2025-04-12 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Option exercise M | +3,125 | – | 363,924 | Form 4 |
| 2025-04-12 | Mecklai HusseinCHIEF OPERATING OFFICER | Option exercise M | +1,094 | – | 76,313 | Form 4 |
| 2025-03-24 | Baker CaryCHIEF FINANCIAL OFFICER | Shares withheld for tax F | −1,436 | 90.25 | 78,662 | Form 4 |
| 2025-03-24 | Mecklai HusseinCHIEF OPERATING OFFICER | Shares withheld for tax F | −1,867 | 90.25 | 75,219 | Form 4 |
| 2025-03-24 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Shares withheld for tax F | −4,363 | 90.25 | 360,799 | Form 4 |
| 2025-03-24 | Phelan Cathal GDirector, CHIEF INNOVATION OFFICER | Shares withheld for tax F | −907 | 90.25 | 9,548 | Form 4 |
| 2025-03-23 | Baker CaryCHIEF FINANCIAL OFFICER | Option exercise M | +782 | – | 77,233 | Form 4 |
| 2025-03-23 | Baker CaryCHIEF FINANCIAL OFFICER | Option exercise M | +479 | – | 77,712 | Form 4 |
| 2025-03-23 | Baker CaryCHIEF FINANCIAL OFFICER | Option exercise M | +2,386 | – | 80,098 | Form 4 |
| 2025-03-23 | Mecklai HusseinCHIEF OPERATING OFFICER | Option exercise M | +1,563 | – | 73,910 | Form 4 |
| 2025-03-23 | Mecklai HusseinCHIEF OPERATING OFFICER | Option exercise M | +529 | – | 74,439 | Form 4 |
| 2025-03-23 | Mecklai HusseinCHIEF OPERATING OFFICER | Option exercise M | +2,647 | – | 77,086 | Form 4 |
| 2025-03-23 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Option exercise M | +2,594 | – | 356,670 | Form 4 |
| 2025-03-23 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Option exercise M | +1,224 | – | 357,894 | Form 4 |
| 2025-03-23 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Option exercise M | +7,268 | – | 365,162 | Form 4 |
| 2025-03-23 | Phelan Cathal GDirector, CHIEF INNOVATION OFFICER | Option exercise M | +414 | – | 8,339 | Form 4 |
| 2025-03-23 | Phelan Cathal GDirector, CHIEF INNOVATION OFFICER | Option exercise M | +2,116 | – | 10,455 | Form 4 |
| 2025-02-24 | Mecklai HusseinCHIEF OPERATING OFFICER | Option exercise M | +2,000 | 17.75 | 72,347 | Form 4 |
| 2025-02-20 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Grant or award A | +20,750 | – | 362,410 | Form 4 |
| 2025-02-20 | Dossett JeffreyCHIEF REVENUE OFFICER | Grant or award A | +7,500 | – | 74,552 | Form 4 |
| 2025-02-20 | Baker CaryCHIEF FINANCIAL OFFICER | Grant or award A | +6,250 | – | 78,004 | Form 4 |
| 2025-02-20 | Mecklai HusseinCHIEF OPERATING OFFICER | Grant or award A | +12,500 | – | 74,086 | Form 4 |
| 2025-02-20 | Phelan Cathal GDirector, CHIEF INNOVATION OFFICER | Option exercise M | +1,375 | – | 8,490 | Form 4 |
| 2025-02-11 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Gift G | −366 | – | 341,660 | Form 4 |
| 2025-02-10 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Option exercise M | +10,000 | 22.40 | 343,856 | Form 4 |
| 2025-02-10 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Gift G | −1,830 | – | 342,026 | Form 4 |
| 2025-01-12 | Mecklai HusseinCHIEF OPERATING OFFICER | Option exercise M | +1,094 | – | 61,924 | Form 4 |
| 2025-01-12 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Option exercise M | +3,125 | – | 334,697 | Form 4 |
| 2025-01-12 | Baker CaryCHIEF FINANCIAL OFFICER | Option exercise M | +937 | – | 72,044 | Form 4 |
| 2025-01-12 | Dossett JeffreyCHIEF REVENUE OFFICER | Option exercise M | +1,250 | – | 67,430 | Form 4 |
| 2024-12-23 | Baker CaryCHIEF FINANCIAL OFFICER | Option exercise M | +781 | – | 71,127 | Form 4 |
| 2024-12-23 | Baker CaryCHIEF FINANCIAL OFFICER | Option exercise M | +479 | – | 71,606 | Form 4 |
| 2024-12-23 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Option exercise M | +2,594 | – | 331,852 | Form 4 |
| 2024-12-23 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Option exercise M | +1,224 | – | 333,076 | Form 4 |
| 2024-12-23 | Dossett JeffreyCHIEF REVENUE OFFICER | Option exercise M | +937 | – | 66,231 | Form 4 |
| 2024-12-23 | Dossett JeffreyCHIEF REVENUE OFFICER | Option exercise M | +529 | – | 66,760 | Form 4 |
| 2024-12-23 | Mecklai HusseinCHIEF OPERATING OFFICER | Option exercise M | +1,562 | – | 61,127 | Form 4 |
| 2024-12-23 | Mecklai HusseinCHIEF OPERATING OFFICER | Option exercise M | +529 | – | 61,656 | Form 4 |
| 2024-12-23 | Phelan Cathal GDirector, CHIEF INNOVATION OFFICER | Option exercise M | +413 | – | 7,189 | Form 4 |
| 2024-11-20 | Phelan Cathal GDirector, CHIEF INNOVATION OFFICER | Option exercise M | +1,375 | – | 7,473 | Form 4 |
| 2024-11-14 | Dossett JeffreyCHIEF REVENUE OFFICER | Option exercise M | +7,500 | 17.33 | 72,794 | Form 4 |
| 2024-11-13 | Dossett JeffreyCHIEF REVENUE OFFICER | Option exercise M | +7,500 | 17.33 | 72,794 | Form 4 |
| 2024-11-07 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Option exercise M | +25,000 | 33.77 | 341,848 | Form 4 |
| 2024-11-06 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Option exercise M | +25,000 | 33.77 | 364,438 | Form 4 |
| 2024-11-06 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Gift G | −35,000 | – | 316,848 | Form 4 |
| 2024-11-01 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Other J | −45,000 | – | 487,494 | Form 4 |
| 2024-11-01 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Other J | +45,000 | – | 339,438 | Form 4 |
| 2024-10-30 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Option exercise M | +526 | 22.40 | 294,964 | Form 4 |
| 2024-10-30 | Mecklai HusseinCHIEF OPERATING OFFICER | Gift G | −476 | – | 59,565 | Form 4 |
| 2024-10-29 | Diorio Chris Ph.d.Director, CHIEF EXECUTIVE OFFICER | Option exercise M | +34,474 | 22.40 | 328,912 | Form 4 |
| 2024-10-29 | Baker CaryCHIEF FINANCIAL OFFICER | Gift G | −750 | – | 70,346 | Form 4 |
| 2024-10-28 | Baker CaryCHIEF FINANCIAL OFFICER | Option exercise M | +13,697 | 33.73 | 84,793 | Form 4 |
| 2024-10-28 | Baker CaryCHIEF FINANCIAL OFFICER | Option exercise M | +1,303 | 26.84 | 86,096 | Form 4 |
| 2024-10-28 | Mecklai HusseinCHIEF OPERATING OFFICER | Option exercise M | +7,040 | 17.75 | 67,081 | Form 4 |
| 2024-10-28 | Mecklai HusseinCHIEF OPERATING OFFICER | Option exercise M | +459 | 36.20 | 67,540 | Form 4 |
| 2024-10-28 | Mecklai HusseinCHIEF OPERATING OFFICER | Option exercise M | +1,688 | 26.84 | 69,228 | Form 4 |
| 2024-10-28 | Mecklai HusseinCHIEF OPERATING OFFICER | Option exercise M | +813 | 26.62 | 70,041 | Form 4 |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.